A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.
about
Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors.Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.Emerging drugs for managing kidney disease in patients with diabetes.Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach.Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculatureFuroxan-Bearing Micelles for Nitric Oxide Delivery.
P2860
A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@en
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@nl
type
label
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@en
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@nl
prefLabel
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@en
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@nl
P2093
P2860
P50
P356
P1476
A novel hybrid aspirin-NO-rele ...... man monocytes and macrophages.
@en
P2093
Adriano G Rossi
Alberto Gasco
Catriona M Turnbull
Clara Cena
Paolo Marcarino
Tara A Sheldrake
P2860
P2888
P356
10.1186/1476-9255-5-12
P577
2008-07-31T00:00:00Z
P5875
P6179
1020927072